Drug Side Effects
Search
AMLODIPINE BESYLATE VALSARTAN HYDROCHLOROTHIAZIDE
AMLODIPINE BESYLATE VALSARTAN HYDROCHLOROTHIAZIDE
was reported 41 times
These side effects are most commonly reported by patients taking AMLODIPINE BESYLATE VALSARTAN HYDROCHLOROTHIAZIDE:
#
Side effect
Count
0
BASAL CELL CARCINOMA
2
1
BLOOD TRIGLYCERIDES INCREASED
2
2
BRONCHITIS
2
3
CLAUDICATION OF JAW MUSCLES
2
4
COMPLETED SUICIDE
2
5
CONDITION AGGRAVATED
2
6
DEATH
2
7
DEPRESSION
2
8
DRUG INEFFECTIVE
2
9
DRUG INTERACTION
2
10
DYSPHONIA
2
11
EAR NEOPLASM
2
12
EYELID PTOSIS
2
13
FALL
2
14
HEADACHE
2
15
HYPERTENSION
2
16
HYPOREFLEXIA
2
17
ILLNESS
2
18
INFLUENZA
2
19
INTERMITTENT CLAUDICATION
2
20
MYASTHENIA GRAVIS
2
21
NAIL DISORDER
2
22
NASOPHARYNGITIS
2
23
NEOPLASM SKIN
2
24
PNEUMONIA
2
25
PRODUCT CONTAMINATION CHEMICAL
2
26
RASH
2
27
RENAL FAILURE
2
28
THERAPEUTIC PRODUCT EFFECT INCOMPLETE
2
29
THROMBOSIS
2
30
ADVERSE DRUG REACTION
1
31
AFFECTIVE DISORDER
1
32
ALOPECIA
1
33
ANKLE FRACTURE
1
34
ANTIBODY TEST POSITIVE
1
35
ASTHMA
1
36
BALANCE DISORDER
1
37
BLINDNESS
1
38
BLOOD CHOLESTEROL INCREASED
1
39
BLOOD GLUCOSE INCREASED
1
40
BLOOD PRESSURE INCREASED
1
41
BODY HEIGHT DECREASED
1
42
BREATH SOUNDS ABNORMAL
1
43
BRONCHIAL DISORDER
1
44
BRONCHIAL HAEMORRHAGE
1
45
BRONCHIAL NEOPLASM
1
46
BURNING SENSATION
1
47
CARDIAC MURMUR
1
48
CATARACT
1
49
CHEST DISCOMFORT
1
50
COUGH
1
51
DEAFNESS
1
52
DRUG INEFFECTIVE FOR UNAPPROVED INDICATION
1
53
DRUG WITHDRAWAL CONVULSIONS
1
54
DRY EYE
1
55
DRY SKIN
1
56
DYSPNOEA
1
57
ENDOMETRIAL ABLATION
1
58
EPISTAXIS
1
59
EXPOSURE DURING PREGNANCY
1
60
EYE HAEMORRHAGE
1
61
FATIGUE
1
62
FEELING ABNORMAL
1
63
GAIT DISTURBANCE
1
64
GALLBLADDER DISORDER
1
65
GASTRITIS
1
66
GASTROINTESTINAL DISORDER
1
67
GLYCOSYLATED HAEMOGLOBIN INCREASED
1
68
GRANULOMA
1
69
HERPES ZOSTER
1
70
HYPERSENSITIVITY
1
71
HYPOKALAEMIA
1
72
HYPOTENSION
1
73
IMMUNE-MEDIATED MYOSITIS
1
74
INFECTION
1
75
INFECTIOUS PLEURAL EFFUSION
1
76
INFLUENZA LIKE ILLNESS
1
77
INJECTION SITE PAIN
1
78
INJECTION SITE REACTION
1
79
INJECTION SITE SWELLING
1
80
JOINT SWELLING
1
81
KIDNEY INFECTION
1
82
LOW DENSITY LIPOPROTEIN INCREASED
1
83
LOWER RESPIRATORY TRACT INFECTION
1
84
LUNG NEOPLASM MALIGNANT
1
85
MALAISE
1
86
MALIGNANT MELANOMA
1
87
MATERNAL EXPOSURE DURING PREGNANCY
1
88
MEMORY IMPAIRMENT
1
89
NASAL CONGESTION
1
90
NASAL TURBINATE HYPERTROPHY
1
91
NEPHROPATHY TOXIC
1
92
OBSTRUCTIVE AIRWAYS DISORDER
1
93
OCULAR HYPERAEMIA
1
94
OEDEMA
1
95
OEDEMA PERIPHERAL
1
96
OSTEOPOROSIS
1
97
OXYGEN SATURATION DECREASED
1
98
PAIN
1
99
PERIPHERAL SWELLING
1
100
PHARYNGITIS
1
101
POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME
1
102
PRODUCT ADMINISTRATION INTERRUPTED
1
103
PRODUCT DOSE OMISSION ISSUE
1
104
PRODUCT PRESCRIBING ERROR
1
105
PRODUCT USE ISSUE
1
106
PRURITUS
1
107
RECALLED PRODUCT
1
108
RECALLED PRODUCT ADMINISTERED
1
109
RESPIRATORY DISORDER
1
110
RHINITIS
1
111
RHONCHI
1
112
SINUS TACHYCARDIA
1
113
SINUSITIS
1
114
SKIN EXFOLIATION
1
115
SKIN FISSURES
1
116
SOMNOLENCE
1
117
SPINAL PAIN
1
118
SUBGALEAL HAEMATOMA
1
119
SYNCOPE
1
120
TRANSIENT ISCHAEMIC ATTACK
1
121
TUMOUR HAEMORRHAGE
1
122
UPPER LIMB FRACTURE
1
123
URINARY TRACT INFECTION
1
124
VERTIGO
1
125
VISUAL IMPAIRMENT
1
126
WEIGHT INCREASED
1
127
WHEEZING
1